Toll Free: 1-888-928-9744

Nanosphere, Inc. (NSPH) - Product Pipeline Analysis, 2016 Update

Published: Jun 8, 2016 | Pages: 42 | Publisher: GlobalData | Industry: Medical Devices | Report Format: Electronic (PDF)

Summary

Nanosphere, Inc. (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company's products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection tests, respiratory infection tests and cardiac tests. Its verigene system is used to identify and treat the bacteria and viruses. Nanosphere offers bloodstream infection tests such as gram-positive blood culture, gram-negative blood culture and yeast blood culture. The company's cardiac tests include CYP2C19, warfarin metabolism and F5/F2/MTHFR. It provides tests for infections of the bloodstream, respiratory tract and gastrointestinal tract. Nanosphere is headquartered in Northbrook, Illinois, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.  

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Nanosphere, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons To Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Nanosphere, Inc. Company Snapshot 6 Nanosphere, Inc. Company Overview 6 Nanosphere, Inc. Pipeline Products and Clinical Trials Overview 7 Nanosphere, Inc.- Pipeline Analysis Overview 9 Key Facts 9 Nanosphere, Inc. - Major Products and Services 10 Nanosphere, Inc. Pipeline Products by Development Stage 11 Nanosphere, Inc. Pipeline Products Overview 13 Next Generation Fully Automated Analyser 13 Next Generation Fully Automated Analyser Product Overview 13 Next Generation Verigene Flex System 14 Next Generation Verigene Flex System Product Overview 14 Processor SP - Multiplex Blood Culture ID Test 15 Processor SP - Multiplex Blood Culture ID Test Product Overview 15 Ultra-Sensitive Assay - Creutzfeldt-Jakob Disease 16 Ultra-Sensitive Assay - Creutzfeldt-Jakob Disease Product Overview 16 Ultra-Sensitive Assay - Alzheimer's Disease 17 Ultra-Sensitive Assay - Alzheimer's Disease Product Overview 17 Ultra-Sensitive Assay - Bladder Cancer 18 Ultra-Sensitive Assay - Bladder Cancer Product Overview 18 Ultra-Sensitive Assay - Colon Cancer 19 Ultra-Sensitive Assay - Colon Cancer Product Overview 19 Ultra-Sensitive Assay - Kidney Cancer 20 Ultra-Sensitive Assay - Kidney Cancer Product Overview 20 Ultra-Sensitive Assay - Non-Cancer Kidney Diseases 21 Ultra-Sensitive Assay - Non-Cancer Kidney Diseases Product Overview 21 Ultra-Sensitive Assay - Ovarian Cancer 22 Ultra-Sensitive Assay - Ovarian Cancer Product Overview 22 Ultra-Sensitive Protein Assay - Autoimmune Disease 23 Ultra-Sensitive Protein Assay - Autoimmune Disease Product Overview 23 Ultra-Sensitive Protein Assay - Cardiac Troponin I 24 Ultra-Sensitive Protein Assay - Cardiac Troponin I Product Overview 24 Ultra-Sensitive Protein Assay - Chronic Heart Failure 25 Ultra-Sensitive Protein Assay - Chronic Heart Failure Product Overview 25 Ultra-Sensitive Protein Assay - Respiratory Disease 26 Ultra-Sensitive Protein Assay - Respiratory Disease Product Overview 26 Ultra-Sensitive Protein Assay - Sepsis 27 Ultra-Sensitive Protein Assay - Sepsis Product Overview 27 Verigene - HFE Nucleic Acid Test 28 Verigene - HFE Nucleic Acid Test Product Overview 28 Verigene Blood Culture - Fungal Test (BC-F) 29 Verigene Blood Culture - Fungal Test (BC-F) Product Overview 29 Verigene Processor SP System - Hemochromatosis (HFE) Nucleic Acid Test 30 Verigene Processor SP System - Hemochromatosis (HFE) Nucleic Acid Test Product Overview 30 Verigene Yeast Blood Culture Test (BC-Y) 31 Verigene Yeast Blood Culture Test (BC-Y) Product Overview 31 Nanosphere, Inc. - Key Competitors 32 Nanosphere, Inc. - Key Employees 33 Nanosphere, Inc. - Locations And Subsidiaries 34 Head Office 34 Recent Developments 35 Nanosphere, Inc., Recent Developments 35 May 16, 2016: Nanosphere Announces First Quarter Results 35 Mar 03, 2016: Nanosphere's Verigene BC-GP Decreases Patient Length of Stay 35 Feb 24, 2016: Nanosphere Announces Fourth Quarter and Full Year 2015 Results, 2016 Guidance and Next Generation Verigene Progress 36 Jan 06, 2016: Nanosphere Announces Record Preliminary Q4 and Full Year 2015 Results 37 Dec 23, 2015: Verigene BC-GN Positioned to Provide Rapid Diagnosis of "Phantom Menace" Superbug 37 Nov 09, 2015: Nanosphere Announces Record Q3 2015 Results 38 Sep 22, 2015: Nanosphere Presents clinical data On Verigene Gram-Negative Blood Culture Test at ICAAC 2015 38 Sep 22, 2015: Nanosphere Presents clinical data On Verigene Gram-Positive Blood Culture Test for rapid sepsis diagnostics at ICAAC 2015 39 Sep 08, 2015: Nanosphere Receives FDA Clearance for First-of-Its-Kind Flexible Respiratory Pathogens Test 40 Aug 10, 2015: Nanosphere Announces Record Q2 2015 Results 40 Appendix 42 Methodology 42 About GlobalData 42 Contact Us 42 Disclaimer 42
List of Tables
Nanosphere, Inc. Pipeline Products and Clinical Trials Overview 7 Nanosphere, Inc. Pipeline Products by Equipment Type 7 Nanosphere, Inc. Pipeline Products by Indication 8 Nanosphere, Inc., Key Facts 9 Nanosphere, Inc., Major Products and Services 10 Nanosphere, Inc. Number of Pipeline Products by Development Stage 11 Nanosphere, Inc. Pipeline Products Summary by Development Stage 12 Next Generation Fully Automated Analyser - Product Status 13 Next Generation Fully Automated Analyser - Product Description 13 Next Generation Verigene Flex System - Product Status 14 Next Generation Verigene Flex System - Product Description 14 Processor SP - Multiplex Blood Culture ID Test - Product Status 15 Processor SP - Multiplex Blood Culture ID Test - Product Description 15 Ultra-Sensitive Assay - Creutzfeldt-Jakob Disease - Product Status 16 Ultra-Sensitive Assay - Creutzfeldt-Jakob Disease - Product Description 16 Ultra-Sensitive Assay - Alzheimer's Disease - Product Status 17 Ultra-Sensitive Assay - Alzheimer's Disease - Product Description 17 Ultra-Sensitive Assay - Bladder Cancer - Product Status 18 Ultra-Sensitive Assay - Bladder Cancer - Product Description 18 Ultra-Sensitive Assay - Colon Cancer - Product Status 19 Ultra-Sensitive Assay - Colon Cancer - Product Description 19 Ultra-Sensitive Assay - Kidney Cancer - Product Status 20 Ultra-Sensitive Assay - Kidney Cancer - Product Description 20 Ultra-Sensitive Assay - Non-Cancer Kidney Diseases - Product Status 21 Ultra-Sensitive Assay - Non-Cancer Kidney Diseases - Product Description 21 Ultra-Sensitive Assay - Ovarian Cancer - Product Status 22 Ultra-Sensitive Assay - Ovarian Cancer - Product Description 22 Ultra-Sensitive Protein Assay - Autoimmune Disease - Product Status 23 Ultra-Sensitive Protein Assay - Autoimmune Disease - Product Description 23 Ultra-Sensitive Protein Assay - Cardiac Troponin I - Product Status 24 Ultra-Sensitive Protein Assay - Cardiac Troponin I - Product Description 24 Ultra-Sensitive Protein Assay - Chronic Heart Failure - Product Status 25 Ultra-Sensitive Protein Assay - Chronic Heart Failure - Product Description 25 Ultra-Sensitive Protein Assay - Respiratory Disease - Product Status 26 Ultra-Sensitive Protein Assay - Respiratory Disease - Product Description 26 Ultra-Sensitive Protein Assay - Sepsis - Product Status 27 Ultra-Sensitive Protein Assay - Sepsis - Product Description 27 Verigene - HFE Nucleic Acid Test - Product Status 28 Verigene - HFE Nucleic Acid Test - Product Description 28 Verigene Blood Culture - Fungal Test (BC-F) - Product Status 29 Verigene Blood Culture - Fungal Test (BC-F) - Product Description 29 Verigene Processor SP System - Hemochromatosis (HFE) Nucleic Acid Test - Product Status 30 Verigene Processor SP System - Hemochromatosis (HFE) Nucleic Acid Test - Product Description 30 Verigene Yeast Blood Culture Test (BC-Y) - Product Status 31 Verigene Yeast Blood Culture Test (BC-Y) - Product Description 31 Nanosphere, Inc., Key Employees 33


List of Figures
Nanosphere, Inc. Pipeline Products by Equipment Type 8 Nanosphere, Inc. Pipeline Products by Development Stage 11

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global Biocides market size is likely to be valued at USD 11.9 billion by 2022; as per a new research report by Radiant Insights, Inc. Growth in water treatment process units particularly in China, Japan and India is likely to drive demand. Increasin

Read More...

Global outsourced customer care services market is projected to reach USD 84.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Swelling need for interaction through non-voice channels is estimated to boost global demand over t

Read More...

Global integrated systems market is projected to reach USD 24 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing need to re-evaluate data center infrastructure is expected to boost the demand. Change in trend from main

Read More...

Global animal feed additives market size was estimated at USD 16 billion in 2014. Growing meat consumption as a key protein source, especially in Asia Pacific and Latin America is expected to be a key driver for market demand over the forecast period

Read More...

Global amino acids market size is anticipated to be valued at USD 35.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in animal feed additive demand owing to regulate metabolism in livestock production owing to growi

Read More...
Choose License Type
Single User - US $750
Multi User - US $1500
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify